Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kintara Therapeutics, Inc.

7.54
+0.0000
Volume:- -
Turnover:801.87K
Market Cap:419.63M
PE:-23.37
High:7.54
Open:7.54
Low:7.54
Close:7.54
Loading ...

Kintara Therapeutics Announces Adjournment of Special Meeting of Stockholders Until October 4, 2024

THOMSON REUTERS
·
20 Sep 2024

Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger With Tuhura Biosciences

THOMSON REUTERS
·
18 Sep 2024

BRIEF-Kintara Therapeutics Provides Update On Corporate Developments And REM-001 Clinical Study

Reuters
·
11 Sep 2024

Kintara Therapeutics Inc - No Treatment-Related Safety Issues Identified in Rem-001 Study

THOMSON REUTERS
·
11 Sep 2024

Kintara Therapeutics Inc - May Seek Bankruptcy Protection Without Tuhura Merger

THOMSON REUTERS
·
11 Sep 2024

Kintara Therapeutics Provides Update on Corporate Developments and Rem-001 Clinical Study

THOMSON REUTERS
·
11 Sep 2024

Kintara Therapeutics Calls for Vote on TuHURA Merger

TIPRANKS
·
09 Sep 2024

Kintara Therapeutics to Hold Special Meeting of Stockholders to Allow for Completion of the Proposed Merger With Tuhura Biosciences, Inc.

THOMSON REUTERS
·
09 Sep 2024

Kintara Therapeutics Announces Special Meeting for TuHURA Merger

TIPRANKS
·
04 Sep 2024

Kintara Therapeutics: Clinical Trial Resumes Amid Merger Uncertainties

TIPRANKS
·
19 Aug 2024

Kintara Therapeutics Eyes Acquisition Amidst Cautionary Advice

TIPRANKS
·
08 Jul 2024

BRIEF-Tuhura Biosciences Enters Into Exclusivity And Right Of First Offer Agreement For Kineta's KVA12123 Novel Anti-Vista Checkpoint Inhibitor

Reuters
·
08 Jul 2024

Kintara Therapeutics Inc - Under Terms of Agreement, Tuhura Will Pay Kineta $5.0 Mln

THOMSON REUTERS
·
08 Jul 2024

BRIEF-Kintara Therapeutics And TuHURA Biosciences Provide Update On Recent Corporate And Clinical Advancements

Reuters
·
01 Jul 2024